We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.56%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$31.3B
AUM Growth
+$1.67B
Cap. Flow
+$1.83B
Cap. Flow %
5.84%
Top 10 Hldgs %
37.77%
Holding
1,441
New
112
Increased
695
Reduced
355
Closed
81

Top Buys

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$698M
2
NFLX icon
Netflix
NFLX
+$243M
3
VTR icon
Ventas
VTR
+$232M
4
META icon
Meta Platforms (Facebook)
META
+$184M
5
AMZN icon
Amazon
AMZN
+$153M

Sector Composition

Rank Sector Weight
1 Technology 30.75%
2 Real Estate 25.79%
3 Communication Services 11.7%
4 Consumer Discretionary 7.26%
5 Financials 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAPT
1276
DELISTED
RAPT Therapeutics
RAPT
$3K ﹤0.01%
+92
New +$2.86K
SANA icon
1277
Sana Biotechnology
SANA
$916M
$3K ﹤0.01%
767
SVRA icon
1278
Savara
SVRA
$1.09B
$3K ﹤0.01%
553
TNGX icon
1279
Tango Therapeutics
TNGX
$4.34B
$3K ﹤0.01%
355
XERS icon
1280
Xeris Biopharma Holdings
XERS
$1.42B
$3K ﹤0.01%
404
XLV icon
1281
State Street Health Care Select Sector SPDR ETF
XLV
$43.2B
$3K ﹤0.01%
19
-14
-42% -$2.1K
XNCR icon
1282
Xencor
XNCR
$1.48B
$3K ﹤0.01%
222
ZLAB icon
1283
Zai Lab
ZLAB
$2.1B
$3K ﹤0.01%
150
ALMS
1284
Alumis Inc
ALMS
$3.45B
$3K ﹤0.01%
347
BCAX
1285
Bicara Therapeutics
BCAX
$1.77B
$3K ﹤0.01%
+182
New +$3.11K
ABSI icon
1286
Absci
ABSI
$1.21B
$2K ﹤0.01%
600
ABUS icon
1287
Arbutus Biopharma
ABUS
$871M
$2K ﹤0.01%
395
-14,100
-97% -$63.4K
ANNX icon
1288
Annexon
ANNX
$814M
$2K ﹤0.01%
352
CGEM icon
1289
Cullinan Oncology
CGEM
$1.07B
$2K ﹤0.01%
218
CMPS
1290
Compass Pathways
CMPS
$1.46B
$2K ﹤0.01%
327
CRMD icon
1291
CorMedix
CRMD
$577M
$2K ﹤0.01%
200
CRVS icon
1292
Corvus Pharmaceuticals
CRVS
$1.12B
$2K ﹤0.01%
225
-175
-44% -$1.38K
CTMX icon
1293
CytomX Therapeutics
CTMX
$701M
$2K ﹤0.01%
+564
New +$2.14K
ELVN icon
1294
Enliven Therapeutics
ELVN
$3.84B
$2K ﹤0.01%
152
ENTA icon
1295
Enanta Pharmaceuticals
ENTA
$367M
$2K ﹤0.01%
+96
New +$1.22K
EOLS icon
1296
Evolus
EOLS
$410M
$2K ﹤0.01%
262
ESPR
1297
DELISTED
Esperion Therapeutics
ESPR
$2K ﹤0.01%
650
ETON icon
1298
Eton Pharmaceutcials
ETON
$1.28B
$2K ﹤0.01%
+89
New +$1.57K
FULC icon
1299
Fulcrum Therapeutics
FULC
$248M
$2K ﹤0.01%
+180
New +$1.83K
LKFT
1300
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$2K ﹤0.01%
51

Similar funds

Daiwa Securities Group's Q4 2025 Portfolio in Review

As of Q4 2025, Daiwa Securities Group held 1,441 positions worth $31.3B, up 5.6% from $29.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group deployed $1.83B of net new capital in Q4 2025, opening 112 new positions and adding to 695 existing holdings. Its largest new stake was iShares Bitcoin Trust: 1,895,000 shares worth $94.1M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Real Estate and Communication Services.

On the sell side, the largest reduction was ServiceNow, an estimated $542M trimmed.

  • Daiwa Securities Group's largest Q4 2025 buy was iShares Bitcoin Trust: 1,895,000 shares worth $94.1M.
  • Daiwa Securities Group added most to Palantir in Q4 2025, an estimated $698M increase.
  • Daiwa Securities Group's biggest Q4 2025 reduction was ServiceNow, cutting an estimated $542M.
  • Daiwa Securities Group fully exited Eagle Materials in Q4 2025, selling an estimated $12.8M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $31.3B portfolio in Q4 2025.
  • Daiwa Securities Group opened 112 new positions and closed 81 in Q4 2025.
  • Daiwa Securities Group's portfolio value rose 5.6% quarter-over-quarter to $31.3B.

Based on Daiwa Securities Group's 13F filing for Q4 2025, filed 11 Feb 2026.